The supply update likely spells the end of widespread GLP-1 compounding in the U.S., which became an immensely popular avenue for patients to access weight loss drugs while Novo and Lillys branded products were in shortage
Like I, every morning Im opening up my, you know, medical newsletters and Im seeing whats being published that day about GLP 1s and what are the doctors saying
As of late 2023, according to reported FDA drug shortages, both forms may be in short supply due to their popularity in helping people lose weight
Hypertension 56 (4), 728733
It helps regenerate other antioxidants, such as Vitamin C, so they can continue protecting your cells
Does DES work better for building mass or cutting